@article {1309,
	title = {Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases.},
	journal = {The American journal of drug and alcohol abuse},
	volume = {33},
	year = {2007},
	month = {2007},
	pages = {869-74},
	abstract = {Hepatitis C virus (HCV) is the most prevalent chronic viral illness in the United States. Many individuals with virus HCV are opioid dependent requiring treatment with opiate substitution treatment such as buprenorphine. Previous reports in the literature have suggested hepatotoxicity with buprenorphine tempering initial enthusiasm of the safety of buprenorphine in HCV-infected patients.},
	keywords = {Adult, Alanine Transaminase, Aspartate Aminotransferases, Bipolar Disorder, Buprenorphine, Cocaine-Related Disorders, Female, Hepatitis B virus, Hepatitis C, Humans, Liver, Liver Function Tests, Male, Naloxone, Narcotic Antagonists, Needle Sharing, Opioid-Related Disorders, RNA, Viral, Transaminases},
	issn = {0095-2990},
	doi = {10.1007/s11904-011-0095-3},
	author = {Bruce, Robert D and Altice, Frederick L}
}
